|
 | Up a level |
Sun, Lucille, Veenstra, David L, Brufsky, Adam, Pluard, Timothy, Sandin, Rickard, Stergiopoulos, Stella, Liu, Xianchen, Williams, Troy and Sullivan, Sean D (2025) First-line cyclin-dependent kinase 4 and 6 inhibitors in combination with an aromatase inhibitor for HR+/HER2- metastatic breast cancer: A real-world cost-effectiveness assessment in a US Medicare-eligible population. Journal of Managed Care & Specialty Pharmacy. pp. 1-12. ISSN 2376-0540
Jofre-Bonet, Mireia, McGuire, Alistair 
ORCID: 0000-0002-5367-9841, Dayer, Victoria, Roth, Joshua A and Sullivan, Sean D
(2025)
The price effects of biosimilars in the United States.
Value in Health, 28 (5).
742 - 750.
ISSN 1098-3015
